Skip to content


Viekira Pak, Exviera (dasabuvir) is a small molecule pharmaceutical. Dasabuvir was first approved as Viekira Pak on 2014-12-19. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Viekira pak's patents are valid until 2033-10-18 (FDA).
Trade Name Exviera
Common Name Dasabuvir
Indication chronic hepatitis c, hepatitis c
Drug Class Antivirals: RNA polymerase (NS5B) inhibitor
Get full access now